Argatroban Injection
Product Images NDC 16729-430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 16729-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Argatroban Figure 1)

FDA Label Image

Figure 2 (Argatroban Figure 2)

FDA Label Image

Figure 3 (Argatroban Figure 3)

Figure 3 (Argatroban Figure 3)
This text appears to be a statistical report of a study with 147 participants, out of which 90 were censored. The study lasted for a maximum of 37 days and had a significant P value of 0.007. The asterisk indicates that there were no clinical endpoints, such as death or amputations.*
FDA Label Image

Figure 4 (Argatroban Figure 4)

FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
This is a label of a medication named "Argatroban inosy" containing 50mg/50mL of the solution to be used solely for Intravenous Infusion. Each mL contains 1 mg of argatroban, 9 mg sodium chloride, USP and 3 mg sorbitol in water for injection, USP. It has a prescribed dosage for Adults. It should be stored at room temperature and should not be refrigerated or frozen. It comes in a Single Dose Vial and leftover portion must be discarded after administering. The label contains a 2D matrix size, lot number (EXP: MMM YYYY) and has instructions to keep the area unvarnished for pasting on it. The label also mentions the manufacturer of the medication.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
This text contains a mixture of gibberish characters, symbols, and alphanumeric codes. The only readable information is the name of a drug called "Argatroban" being injected intravenously without dilution. Dosage information is also included. No useful description can be generated from this text.*
FDA Label Image

Principal Display Panel (Vial Label)

Principal Display Panel (Vial Label)
This is a drug containing 1mg of argatroban, 9mg of sodium chloride, and 3mg of sorbiol in each ml. It is administered by intravenous infusion only and is available in a single-dose vial. It should not be used if the solution is cloudy or contains a precipitate. The drug should be stored at room temperature between 20°C to 25°C (68°F to 77°F) and protected from light. Dilution prior to administration is not recommended. The usual adult dosage should be referred from the prescribing information.*
FDA Label Image

Structural Formula (Argatroban Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.